Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B. Riley Securities Downgrades Digital Turbine to Neutral, Announces $16 Price Target

B. Riley Securities Downgrades Digital Turbine to Neutral, Announces $16 Price Target

B. Riley Securities analyst Daniel Day downgrades Digital Turbine (NASDAQ:APPS) from Buy to Neutral and announces $16 price target.

byBenzinga Newsdesk

February 1, 2023

1 minute read

B. Riley Securities analyst Daniel Day downgrades Digital Turbine (NASDAQ:APPS) from Buy to Neutral and announces $16 price target.

Analyst Ratings

Analyst Ratings for bluebird bio

By Benzinga Insights

March 30, 1:00 PM

Over the past 3 months, 6 analysts have published their opinion on bluebird bio (NASDAQ:BLUE) stock. These analysts…

BLUE

Analyst Ratings

Analyst Expectations for Ares Capital’s Future

By Benzinga Insights

June 16, 2:01 PM

Ares Capital (NASDAQ:ARCC) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

ARCC

Ansell Acquires Kimberly-Clark’s Protective Equipment Business For $640M

By Shivani Kumaresan

April 8, 8:26 AM

Ansell seals a binding agreement to acquire 100% of the assets that constitute Kimberly-Clark's Personal Protective Equipment business (KCPPE) for $640 million.

ANSLY

Guggenheim Initiates Coverage On Mineralys Therapeutics with Buy Rating, Announces Price Target of $32

By Benzinga Newsdesk

March 7, 8:10 AM

Guggenheim analyst Seamus Fernandez initiates coverage on Mineralys Therapeutics (NASDAQ:MLYS) with a Buy rating and announces Price Target of $32.

MLYS

B. Riley Securities Downgrades Digital Turbine to Neutral, Announces $16 Price Target

Related Posts

Analyst Ratings for bluebird bio

Analyst Expectations for Ares Capital’s Future

Ansell Acquires Kimberly-Clark’s Protective Equipment Business For $640M

Guggenheim Initiates Coverage On Mineralys Therapeutics with Buy Rating, Announces Price Target of $32